Dr. Andrea Sautter

Andrea is member of the Practice Area Patents Technology & Life Sciences and the Life Sciences & Healthcare Industry Group.

Her practice includes advising national and international pharmaceutical and biotech companies, medical product manufacturers and food product producers on intellectual property law and regulatory issues. A focus of her practice is advising on complex, often cross-border, projects, in particular research and development cooperations, manufacturing and distribution agreements and licences, as well as advice on transactions.

Show full CV Hide full CV

Career

Since 2015	Senior Associate, Taylor Wessing
Since 2012	Lecturer for presentation methods, University of Mannheim
2010 – 2012	Research and teaching Assistant, Institute for Medical Law of the Universities of Heidelberg and Mannheim (IMGB)

Education

2018	Ph.D. in law, University of Mannheim
2015	Admitted as a lawyer, Munich
2015	Second state examination, Wiesbaden

2013 – 2015	Legal clerkship including stages at an international law firm in Frankfurt; the legal department of a healthcare corporation in Bad Homburg v.d.H and the German Desk of a Korean law firm in Seoul
2012	Additional qualification in pharmaceutical law, University in Marburg
2010	First state examination
2005 – 2010	Legal studies, University of Mannheim

More Less

Additional languages

English

Expertise

Services and Groups Patents & innovation

Sectors Life sciences & healthcare Biotech Cosmetics, food nutrition & supplements Medical devices Pharmaceuticals

Experience

Steadfast Capital Fund IV on the acquisition of a majority stake in Söhngen Group

Steadfast Capital Fund IV on the acquisition of a majority stake in Söhngen Group. The transaction included both W. Söhngen GmbH based in Taunusstein (Hesse) and Silva GmbH based in Mainhausen (Hesse). The parties have agreed not to disclose the purchase price. The majority acquisition aims to support further growth of the Söhngen Group with its internationally recognised brands and premium products in the market for first aid and emergency medical products both organically and through acquisitions. We also advised on the financing of the acquisition.